FIRST ON FOX: Newly obtained public records show Cercle Allocation Services billed a UCLA research operation a $765 procurement-service fee tied to each individual liver and thymus specimen, while warning in internal correspondence that certain billing language could improperly imply the tissue itself was being sold.The records, obtained from UCLA through a California Public Records Act request made on behalf of Center for Medical Progress founder David Daleiden, include purchase orders and correspondence between the university and Cercle Allocation Services.An internal UCLA order form identifies the purchasing operation as part of the David Geffen School of Medicine’s Division of Hematology-Oncology and references the "Mouse Core." UCLA redacted the names and other identifying information of researchers from the record.The records reviewed by Fox News Digital do not establish that UCLA or its researchers, procurement personnel or other employees, engaged in illegal or unethical conduct in connection with the transactions.'DRUG-DEALING' NETWORK SHIELDED BY BLUE STATES TARGETED IN SCOTUS CHALLENGEFILE - Cercle supplies human fetal tissue for biomedical research.(Shane Collins, Northwestern University)One UCLA purchase order lists seven individually numbered liver and thymus specimens at a $765 unit amount apiece, totaling $5,355.
Another lists five specimens from Aug.18, 2023, each carrying the same $765 amount, for a total of $3,825.
Additional purchase orders reflect the same per-specimen amount.Cercle objected to the purchase orders’ tax treatment and asked UCLA to reissue them, telling the university that the charges reflected procurement services and that sales tax should not be applied.Cercle said tax language could improperly imply that the specimens themselves were being sold.Cercle does supply human fetal tissue for biomedical research.
Peer-reviewed scientific literature has identified the company as the source of human fetal liver tissue used by res...